The House on Tuesday voted 250-169 in favor of the bill which the Senate passed in August Xinhua reported.
Under the legislation terminally ill patients have the right to seek drug treatments that remain in clinical trials after passing phase 1 of the FDA approval process.
--IANS ahm/